MarAprMayJun
↩ TodayMon23Mar
Tue24Mar
Wed25Mar
Thu26Mar
Fri27Mar
Sat28Mar
Sun29Mar
Mon30Mar
Tue31Mar
Wed1Apr
Thu2Apr
Fri3Apr
Sat4Apr
Sun5Apr
Mon6Apr
Tue7Apr
Wed8Apr
Fri10Apr
Sat11Apr
Mon13Apr
Tue14Apr
Wed15Apr
Thu16Apr
Fri17Apr
Sat18Apr
Sun19Apr
Mon20Apr
Tue21Apr
Wed22Apr
Thu23Apr
Fri24Apr
Sat25Apr
Sun26Apr
Mon27Apr
Tue28Apr
Wed29Apr
Thu30Apr
Fri1May
Sat2May
Sun3May
Mon4May
Tue5May
Wed6May
Thu7May
Fri8May
Sat9May
Sun10May
Mon11May
Tue12May
Wed13May
Thu14May
Fri15May
Sat16May
Sun17May
Mon18May
Tue19May
Wed20May
Thu21May
Fri22May
Sat23May
Sun24May
Mon25May
Tue26May
Wed27May
Thu28May
Fri29May
Sat30May
Sun31May
Mon1Jun
Tue2Jun
Wed3Jun
Thu4Jun
Fri5Jun
Sat6Jun
Sun7Jun
Mon8Jun
Tue9Jun
Wed10Jun
Thu11Jun
Fri12Jun
Sat13Jun
Sun14Jun
Mon15Jun
Tue16Jun
Wed17Jun
Thu18Jun
Fri19Jun
Sat20Jun
Sun21Jun
Mon22Jun
Wed24Jun
Thu25Jun
Fri26Jun
Sat27Jun
10 papers read · 10 surfaced · 0 stood out
Today's lead · Early Detection
Identification and validation of liquid biopsy-based methylation…
Blood tests can now detect specific germ cell tumor types through DNA patterns, potentially replacing more invasive diagnostic procedures.
Janssen FW, Gillis AJM, Gouswaart PB et al. · Communications Medicine
7/10
Impact score
Time to impact (est.)
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Novel or significantly improved treatment
Convergent evolution of complex structural variants drives therapy…
Cancer resistance patterns circulating in blood can be detected early, offering doctors a way to monitor therapy response without repeated biopsies.
Promising but preliminaryIntracellular IL-23R is necessary for mitotic spindle formation and…
A newly discovered vulnerability in leukemia cells could be exploited therapeutically while leaving healthy blood cells unharmed.
Promising but preliminaryQuizartinib-induced resistance drives clonal emergence of MV4-11…
When leukemia develops resistance to one drug, adding a second drug targeting the resistance mechanism restores sensitivity in lab models.
Promising but preliminaryPRMT5 inhibition sensitizes B-cell lymphoma cells to ferroptosis
Combining an experimental drug with an existing compound triggers a two-pronged death pathway in aggressive lymphomas that resisted prior treatment.